NASDAQ: PRLD

Analyst Snapshot

A look at PRLD’s current quarter earnings estimates

Kenneth Phillips

Currently, Prelude Therapeutics Inc’s (PRLD) stock is trading at $2.71, marking a fall of -6.55% from last night’s close. At ...

Analyst Snapshot

A look at PRLD’s current quarter earnings estimates

Kenneth Phillips

Currently, Prelude Therapeutics Inc’s (PRLD) stock is trading at $2.71, marking a fall of -6.55% from last night’s close. At ...

Analyst Snapshot

A look at PRLD’s current quarter earnings estimates

Kenneth Phillips

At this price, the stock is -32.70% below its 52-week high of $4.22 and 365.50% above its 52-week low of ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.